Technical Analysis for ICAD - icad inc.

Grade Last Price % Change Price Change
grade B 7.05 3.07% 0.21
ICAD closed up 3.07 percent on Tuesday, September 17, 2019, on 1.65 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical ICAD trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Upper Bollinger Band Walk Strength 0.00%
Outside Day Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Stochastic Sell Signal Bearish 3.07%
Upper Bollinger Band Walk Strength 3.07%
Overbought Stochastic Strength 3.07%
Upper Bollinger Band Touch Strength 3.07%

Older signals for ICAD ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy that enable healthcare professionals and radiologists to identify pathologies and pinpoint cancer earlier. It offers Axxent eBx system, which is used for the treatment of early stage breast cancer, endometrial cancer, and skin cancer, as well as for the treatment of other cancers or conditions where radiation therapy is indicated. It also provides computer-aided detection (CAD) solutions for digital and film-based mammography systems, including SecondLook systems that detects and identifies masses and micro-calcifications; and PowerLook Advanced Mammography Platform, a computer server residing on a customer's network that receives patient studies from the imaging modality, performs CAD analysis, and sends the CAD results to PACS and/or review workstations. In addition, the company offers image analysis and workflow solutions in MRI imaging comprising SpectraLook for breast, VividLook for prostate, and OmniLook for other organs; and VersaVue Enterprise, a review and reporting solution, which provides visual and quantitative depictions of the movement of contrast agent through a lesion. Further, it provides VeraLook that supports the detection of colonic polyps in conjunction with CT Colonography; and the TotalLook MammoAdvantage system, a mammography specific digitizer. The company sells its products to hospitals, ambulatory care centers, and free standing radiation oncology facilities. It sells its products directly, as well as through various original equipment manufacturer partners, distributors, and resellers worldwide. The company was founded in 1984 and is headquartered in Nashua, New Hampshire.
Medicine Health Cancer Imaging Cancers Radiation Medical Imaging Breast Cancer Healthcare Professionals Radiation Therapy CAD MRI Workflow Solutions Cancer Screening Mammography Skin Cancer Breast Imaging Endometrial Cancer Picture Archiving And Communication System
Is ICAD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 7.45
52 Week Low 2.425
Average Volume 97,194
200-Day Moving Average 5.4384
50-Day Moving Average 6.4112
20-Day Moving Average 6.2935
10-Day Moving Average 6.603
Average True Range 0.4064
ADX 19.95
+DI 28.7872
-DI 11.3633
Chandelier Exit (Long, 3 ATRs ) 6.1708
Chandelier Exit (Short, 3 ATRs ) 6.7292
Upper Bollinger Band 7.1438
Lower Bollinger Band 5.4432
Percent B (%b) 0.94
BandWidth 27.02153
MACD Line 0.1709
MACD Signal Line 0.0534
MACD Histogram 0.1175
Fundamentals Value
Market Cap 116.99 Million
Num Shares 16.6 Million
EPS -0.56
Price-to-Earnings (P/E) Ratio -12.59
Price-to-Sales 2.98
Price-to-Book 3.16
PEG Ratio -0.58
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.98
Resistance 3 (R3) 7.99 7.69 7.83
Resistance 2 (R2) 7.69 7.45 7.69 7.77
Resistance 1 (R1) 7.37 7.31 7.53 7.36 7.72
Pivot Point 7.07 7.07 7.15 7.07 7.07
Support 1 (S1) 6.75 6.83 6.91 6.74 6.38
Support 2 (S2) 6.45 6.69 6.45 6.33
Support 3 (S3) 6.13 6.45 6.28
Support 4 (S4) 6.12